Javascript must be enabled to continue!
Quarantine Powers, Biodefense, and Andrew Speaker
View through CrossRef
In January 2007, Andrew Speaker (Speaker) underwent a chest X-ray and CT scan, which revealed an abnormality in his lungs. However, tests results indicated that he did not have tuberculosis (TB). In March 2007, Fulton County officials informed Andrew Speaker that he was diagnosed with a form of non-infectious form of tuberculosis. He was prescribed a regimen of first-line anti-TB drugs. Fulton County officials confirmed the positive TB result, and further tests were ordered. These tests indicated that Speaker had MDR-TB. Fulton County officials told Speaker not to travel abroad for his upcoming wedding in Europe; however, he ignored them. Unbeknownst to any health official, Speaker departed Atlanta for Europe on May 12, 2007. Two weeks later, the Center for Disease Control (CDC) informed him that his diagnosis had changed and that he had a drug-resistant form of tuberculosis named XDR-TB. Speaker was in Rome at the time. CDC officials directed him to turn himself into Italian authorities for isolation and asked that he not return home on commercial airlines. Speaker was even placed on a no fly list by the CDC. Again, Speaker ignored CDC officials and returned to the United States via Canada. From Prague, Speaker flew back to Montreal on two commercial aircrafts, and on May 25, 2007, Speaker entered the United States from Canada by car. Despite being aware of the border alert, the border guard allowed Speaker into the United States. Once in the United States, CDC officials served Speaker with an isolation order and hospitalized him at Bellevue Hospital in New York City. CDC officials placed him in a secure part of the hospital, where he underwent a medical evaluation to determine the status of his TB. Speaker was then allowed to return to Atlanta, where he faced intense media scrutiny. He then was transferred to the National Jewish Medical Center in Denver for further treatment of his XDR-TB. Eventually, however, officials downgraded his diagnosis to MDR-TB as they had originally. Speaker had surgery to remove the lung infected with MDR-TB at the end of July, and he was declared non-contagious.Clearly, Speaker sparked significant interest in public health on both the national and international levels. Speakers initial disregard for United States authority created an opportunity for criticism of local, state, and federal public health laws, while Speakers subsequent disregard of authorities while abroad allowed for questioning of international public health law and in particular, the effectiveness of the International Health Regulations. This overview explains certain areas of national and international public health law, and Speakers impact on these areas.
Title: Quarantine Powers, Biodefense, and Andrew Speaker
Description:
In January 2007, Andrew Speaker (Speaker) underwent a chest X-ray and CT scan, which revealed an abnormality in his lungs.
However, tests results indicated that he did not have tuberculosis (TB).
In March 2007, Fulton County officials informed Andrew Speaker that he was diagnosed with a form of non-infectious form of tuberculosis.
He was prescribed a regimen of first-line anti-TB drugs.
Fulton County officials confirmed the positive TB result, and further tests were ordered.
These tests indicated that Speaker had MDR-TB.
Fulton County officials told Speaker not to travel abroad for his upcoming wedding in Europe; however, he ignored them.
Unbeknownst to any health official, Speaker departed Atlanta for Europe on May 12, 2007.
Two weeks later, the Center for Disease Control (CDC) informed him that his diagnosis had changed and that he had a drug-resistant form of tuberculosis named XDR-TB.
Speaker was in Rome at the time.
CDC officials directed him to turn himself into Italian authorities for isolation and asked that he not return home on commercial airlines.
Speaker was even placed on a no fly list by the CDC.
Again, Speaker ignored CDC officials and returned to the United States via Canada.
From Prague, Speaker flew back to Montreal on two commercial aircrafts, and on May 25, 2007, Speaker entered the United States from Canada by car.
Despite being aware of the border alert, the border guard allowed Speaker into the United States.
Once in the United States, CDC officials served Speaker with an isolation order and hospitalized him at Bellevue Hospital in New York City.
CDC officials placed him in a secure part of the hospital, where he underwent a medical evaluation to determine the status of his TB.
Speaker was then allowed to return to Atlanta, where he faced intense media scrutiny.
He then was transferred to the National Jewish Medical Center in Denver for further treatment of his XDR-TB.
Eventually, however, officials downgraded his diagnosis to MDR-TB as they had originally.
Speaker had surgery to remove the lung infected with MDR-TB at the end of July, and he was declared non-contagious.
Clearly, Speaker sparked significant interest in public health on both the national and international levels.
Speakers initial disregard for United States authority created an opportunity for criticism of local, state, and federal public health laws, while Speakers subsequent disregard of authorities while abroad allowed for questioning of international public health law and in particular, the effectiveness of the International Health Regulations.
This overview explains certain areas of national and international public health law, and Speakers impact on these areas.
Related Results
The psychological well‐being of people in a COVID‐19 supervised quarantine facility: A mixed methods study
The psychological well‐being of people in a COVID‐19 supervised quarantine facility: A mixed methods study
Accessible summaryWhat is known on the subject?
Supervised Quarantine has been shown to impact the psychological well‐being of those in quarantine both during the COVID‐19 pandem...
Increasing Nursing Research Opportunities in Biodefense: National Institute of Nursing Research Science Workgroup
Increasing Nursing Research Opportunities in Biodefense: National Institute of Nursing Research Science Workgroup
The threat of bioterrorism and the need for biodefense are new challenges for the scientific community. Bioterrorism already has had significant effects on the nation’s health. Res...
Does Quarantine of Wuhan Effectively Restrict Early Geographic Spread of Novel Coronavirus Epidemic During Chunyun in China? a Spatial Model Study
Does Quarantine of Wuhan Effectively Restrict Early Geographic Spread of Novel Coronavirus Epidemic During Chunyun in China? a Spatial Model Study
Abstract
BackgroundPrior to Wuhan quarantine in 2020, chunyun, the largest population mobility on this planet, had begun. We quantify impacts of Wuhan quarantine on COVID-1...
Fusion of Cochleogram and Mel Spectrogram Features for Deep Learning Based Speaker Recognition
Fusion of Cochleogram and Mel Spectrogram Features for Deep Learning Based Speaker Recognition
Abstract
Speaker recognition has crucial application in forensic science, financial areas, access control, surveillance and law enforcement. The performance of speaker reco...
Analyzing Noise Robustness of Cochleogram and Mel Spectrogram Features in Deep Learning Based Speaker Recogntion
Analyzing Noise Robustness of Cochleogram and Mel Spectrogram Features in Deep Learning Based Speaker Recogntion
Abstract
The performance of speaker recognition is very well in a clean dataset or without mismatch between training and test set. However, the performance is degraded with...
1924-LB: Clinical Performance of a Novel CGM System
1924-LB: Clinical Performance of a Novel CGM System
Introduction and Objective: The use of continuous glucose monitoring (CGM) improves glycemic control in people with diabetes (PwD). The availability of multiple systems with high a...
Introduction: Volume 3 of the Journal of Biosecurity, Biosafety & Biodefense Law
Introduction: Volume 3 of the Journal of Biosecurity, Biosafety & Biodefense Law
Abstract
The purpose of this document is to provide an introduction and overview regarding the substantive materials included in Volume 3 of the Journal for Biosecur...
Introduction: Volume 2 of the Journal of Biosecurity, Biosafety & Biodefense Law
Introduction: Volume 2 of the Journal of Biosecurity, Biosafety & Biodefense Law
We are pleased to publish Volume 2, of the Journal for Biosecurity, Biosafety and Biodefense Law. This volume, like the first volume, continues to raise new and important legal iss...

